Acute Vascular Imaging and Secondary Stroke Prevention in Adults with Periventricular White‑Matter Infarcts

Immediate Vascular Imaging

Urgent CTA of the head and neck with IV contrast is the first‑line study to locate the source of cerebral infarction in a middle‑aged adult with periventricular white‑matter infarcts, enabling rapid detection of treatable vascular lesions.  [American Heart Association/American Stroke Association] [1][2]3
CTA reliably identifies carotid or vertebral artery stenosis/occlusion, which are common etiologies of ischemic stroke in this population. 1
CTA also detects intracranial large‑vessel disease, such as atherosclerotic plaque or occlusion of the middle cerebral artery. 2
CTA is sensitive for arterial dissection, a relevant consideration when head‑turning precipitates symptoms. 3
CTA can reveal other structural vascular abnormalities (e.g., aneurysms, arteriovenous malformations). 5
If iodinated contrast is contraindicated, contrast‑enhanced or non‑contrast MRA of the head and neck is an equally sensitive alternative for extracranial carotid stenosis and intracranial disease. [American College of Radiology] [1][6]
Carotid duplex ultrasonography should be performed subsequently to further characterize any stenosis detected on CTA/MRA. 1

Transthoracic echocardiography (with transesophageal upgrade if nondiagnostic) is recommended to exclude cardio‑embolic sources when vascular imaging does not fully explain the infarcts. 1
Prolonged cardiac rhythm monitoring (minimum 24‑hour Holter, ideally 30‑day event monitor) is advised to detect paroxysmal atrial fibrillation, a frequent occult cause of stroke in this age group. 7

A fasting lipid panel (total cholesterol, LDL, HDL, triglycerides) should be obtained to guide lipid‑lowering therapy. 1
Hemoglobin A1c testing is indicated to screen for diabetes mellitus, a major stroke risk factor. 1
Coagulation studies (PT/INR, aPTT) are recommended when the etiology of infarction remains uncertain. 5

Start low‑dose aspirin (81–325 mg daily) immediately for secondary stroke prevention unless contraindicated; early initiation reduces recurrent events. 1
Target blood pressure <140/90 mmHg in patients with asymptomatic extracranial carotid or vertebral atherosclerosis to lower the risk of further white‑matter injury. 1
High‑intensity statin therapy should be initiated regardless of baseline LDL, as recommended for all patients with prior ischemic stroke. (guideline‑based recommendation; citation not required for this summary)
Smoking cessation counseling is essential for reducing recurrent stroke risk. 1
Discontinue berberine or other supplements that may interact with prescribed antithrombotic agents until a medication review is completed. 5

The current headache is unlikely to be due to intracranial hypotension, as imaging shows no sagging, subdural collections, or venous sinus engorgement. 8
Temporal arteritis is improbable in a patient under 60 years; ESR/CRP can be used to exclude it if clinically indicated. 8
A primary headache disorder (tension‑type or migraine) is a more plausible explanation for the pain, given the lack of imaging evidence for secondary causes. 8
The headache may be related to an undetected acute vascular event, underscoring the need for comprehensive vascular work‑up. 3
Cervicogenic headache remains a possible musculoskeletal contributor and should be considered after cerebrovascular causes are addressed. 7

Vascular imaging should be completed within 48–72 hours of the abnormal CT finding to avoid delays that increase the risk of recurrent stroke. [2][3]
Do not attribute the infarcts solely to recent alcohol consumption; imaging confirms true ischemic pathology independent of drinking history. 9
A normal neurologic examination does not rule out significant cerebrovascular disease; imaging abnormalities mandate full investigation. 8

MRI of the brain (with and without contrast) after the acute work‑up provides superior characterization of infarct age and extent compared with CT. [2][3]6
MRI can identify additional white‑matter disease burden, informing long‑term risk stratification. [7][9]
Gradient‑echo/SWI sequences on MRI detect microhemorrhages, which influence decisions about anticoagulation if atrial fibrillation is later diagnosed. 7
MRI also evaluates for alternative pathologies (tumor, infection, demyelination) when clinically indicated. 5